Daiichi Financial Statements From 2010 to 2024
DSKYF Stock | USD 30.19 2.30 8.25% |
Check Daiichi Sankyo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Daiichi Sankyo's main balance sheet or income statement drivers, such as , as well as many indicators such as . Daiichi financial statements analysis is a perfect complement when working with Daiichi Sankyo Valuation or Volatility modules.
Daiichi |
Daiichi Sankyo Company Operating Margin Analysis
Daiichi Sankyo's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Daiichi Sankyo Operating Margin | 0.06 % |
Most of Daiichi Sankyo's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Daiichi Sankyo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Daiichi Sankyo has an Operating Margin of 0.0646%. This is 100.18% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 101.17% lower than that of the firm.
Daiichi Sankyo Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Daiichi Sankyo's current stock value. Our valuation model uses many indicators to compare Daiichi Sankyo value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Daiichi Sankyo competition to find correlations between indicators driving Daiichi Sankyo's intrinsic value. More Info.Daiichi Sankyo is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Daiichi Sankyo is roughly 2.07 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Daiichi Sankyo's earnings, one of the primary drivers of an investment's value.About Daiichi Sankyo Financial Statements
Daiichi Sankyo stakeholders use historical fundamental indicators, such as Daiichi Sankyo's revenue or net income, to determine how well the company is positioned to perform in the future. Although Daiichi Sankyo investors may analyze each financial statement separately, they are all interrelated. For example, changes in Daiichi Sankyo's assets and liabilities are reflected in the revenues and expenses on Daiichi Sankyo's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Daiichi Sankyo. Please read more on our technical analysis and fundamental analysis pages.
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company was founded in 1899 and is headquartered in Tokyo, Japan. Daiichi Sankyo operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 16458 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Daiichi Pink Sheet
Daiichi Sankyo financial ratios help investors to determine whether Daiichi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Daiichi with respect to the benefits of owning Daiichi Sankyo security.